Povero, M. (2021) “Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy”, Farmeconomia. Health economics and therapeutic pathways, 22(1). doi: 10.7175/fe.v22i1.1499.